Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Nichi-Iko Secures Up To ¥98.5bn Debt Relief As ADR Pushes Ahead
Company Is Set To Delist From Tokyo Stock Exchange Later This Year
Jan 06 2023
•
By
Chloe Kent
Nichi-Iko explained that its debt forgiveness has currently been fixed at ¥55.8bn • Source: Shutterstock
More from Strategy
More from Business
